Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 3 Pain, Postoperative 2 Neoplasms 2 Head and Neck Neoplasms 2 Wounds and Injuries 1 Supratentorial Neoplasms 1 Sigmoidal Tumour 1 Rectal Neoplasms 1 Pleural Effusion, Malignant 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pain, Intractable 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Nalbuphine Allergy 1 Immune System Suppression 1 Ileus 1 Diverticulosis, Colonic 1 Diverticulitis, Colonic 1 Constipation 1 Colonic Neoplasms 1 Chronic Pain 1 Cancer Pain 1 Breast Neoplasms 1 Breast Cancer Patients Undergoing Mastectomy With Immediate Reconstruction 1 Agnosia 1

Interventions

ziconotide 1 Ropivacaine 1 Morphine 1 Methadone 1 Lidocaine 1 Calcium Dobesilate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Pain, Intractable × Morphine × Clear all

NCT02687347 2016-09-20

UDOME

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase 3 Unknown

Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon ⚡